Warren Buffett - Berkshire Hathaway 13F Activity & Position Changes (Q3 2021)
As of Sep 30, 2021, the Berkshire Hathaway portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Nov 15, 2021. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q3 2021, the filing reported:
New Buys - Floor & Decor Holdings, Inc., Royalty Pharma
Increases - Chevron Corporation
Reductions - AbbVie Inc., Bristol-Myers Squibb Company, Charter Communications, Inc., Mastercard Incorporated, Marsh & McLennan Companies, Inc, and 2 more
Complete Exits - Merck & Company, Inc., Organon & Co.
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q3 2021
|
ABBV
AbbVie Inc.
|
Sell |
-6,129,373
|
|
Q3 2021
|
BMY
Bristol-Myers Squibb Company
|
Sell |
-4,247,330
|
|
Q3 2021
|
CHTR
Charter Communications, Inc.
|
Sell |
-1,012,835
|
|
Q3 2021
|
CVX
Chevron Corporation
|
Buy |
+5,579,599
|
|
Q3 2021
|
FND
Floor & Decor Holdings, Inc.
|
Buy - Position Entry |
+816,863
|
|
Q3 2021
|
MA
Mastercard Incorporated
|
Sell |
-276,108
|
|
Q3 2021
|
MMC
Marsh & McLennan Companies, Inc
|
Sell |
-1,454,937
|
|
Q3 2021
|
MRK
Merck & Company, Inc.
|
Sell - Position Exit |
-9,157,192
|
|
Q3 2021
|
OGN
Organon & Co.
|
Sell - Position Exit |
-1,550,481
|
|
Q3 2021
|
RPRX
Royalty Pharma
|
Buy - Position Entry |
+13,145,902
|
|
Q3 2021
|
USB
U.S. Bancorp
|
Sell |
-2,471,019
|
|
Q3 2021
|
V
Visa Inc.
|
Sell |
-425,000
|